Amisulpride versus fluoxetine in dysthymia

Preliminary results of a double-blind comparative study

E. Smeraldi, E. Haefele, G. Crespi, G. L. Casadei, F. Biondi, E. Vigorelli

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The efficacy and safety of low doses of amisulpride (50 mg/day) and of fluoxetine (20 mg/day) were compared respectively in 139 and 129 outpatients with dysthymia during three months in a multi-centre double-blind trial. No statistically significant difference between the two groups was found in the number of responders at study-end with the Montgomery and Asberg Depressive Rating Scale, which was the main criterion for efficacy. In addition, amisulpride was well tolerated. These preliminary results suggest that low doses of amisulpride may be effective in the treatment of dysthymic patients.

Original languageEnglish
JournalEuropean Psychiatry
Volume11
Issue numberSUPPL. 3
DOIs
Publication statusPublished - 1996

Fingerprint

Fluoxetine
Double-Blind Method
Outpatients
Safety
sultopride
Therapeutics

Keywords

  • amisulpride
  • benzamide
  • dysthymia
  • fluoxetine
  • treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Smeraldi, E., Haefele, E., Crespi, G., Casadei, G. L., Biondi, F., & Vigorelli, E. (1996). Amisulpride versus fluoxetine in dysthymia: Preliminary results of a double-blind comparative study. European Psychiatry, 11(SUPPL. 3). https://doi.org/10.1016/0924-9338(96)85189-3

Amisulpride versus fluoxetine in dysthymia : Preliminary results of a double-blind comparative study. / Smeraldi, E.; Haefele, E.; Crespi, G.; Casadei, G. L.; Biondi, F.; Vigorelli, E.

In: European Psychiatry, Vol. 11, No. SUPPL. 3, 1996.

Research output: Contribution to journalArticle

Smeraldi, E, Haefele, E, Crespi, G, Casadei, GL, Biondi, F & Vigorelli, E 1996, 'Amisulpride versus fluoxetine in dysthymia: Preliminary results of a double-blind comparative study', European Psychiatry, vol. 11, no. SUPPL. 3. https://doi.org/10.1016/0924-9338(96)85189-3
Smeraldi, E. ; Haefele, E. ; Crespi, G. ; Casadei, G. L. ; Biondi, F. ; Vigorelli, E. / Amisulpride versus fluoxetine in dysthymia : Preliminary results of a double-blind comparative study. In: European Psychiatry. 1996 ; Vol. 11, No. SUPPL. 3.
@article{95b977dd45984efba95d1a334748421f,
title = "Amisulpride versus fluoxetine in dysthymia: Preliminary results of a double-blind comparative study",
abstract = "The efficacy and safety of low doses of amisulpride (50 mg/day) and of fluoxetine (20 mg/day) were compared respectively in 139 and 129 outpatients with dysthymia during three months in a multi-centre double-blind trial. No statistically significant difference between the two groups was found in the number of responders at study-end with the Montgomery and Asberg Depressive Rating Scale, which was the main criterion for efficacy. In addition, amisulpride was well tolerated. These preliminary results suggest that low doses of amisulpride may be effective in the treatment of dysthymic patients.",
keywords = "amisulpride, benzamide, dysthymia, fluoxetine, treatment",
author = "E. Smeraldi and E. Haefele and G. Crespi and Casadei, {G. L.} and F. Biondi and E. Vigorelli",
year = "1996",
doi = "10.1016/0924-9338(96)85189-3",
language = "English",
volume = "11",
journal = "Psychiatrie et Psychobiologie",
issn = "0924-9338",
publisher = "Psychiatrie & psychobiologie",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Amisulpride versus fluoxetine in dysthymia

T2 - Preliminary results of a double-blind comparative study

AU - Smeraldi, E.

AU - Haefele, E.

AU - Crespi, G.

AU - Casadei, G. L.

AU - Biondi, F.

AU - Vigorelli, E.

PY - 1996

Y1 - 1996

N2 - The efficacy and safety of low doses of amisulpride (50 mg/day) and of fluoxetine (20 mg/day) were compared respectively in 139 and 129 outpatients with dysthymia during three months in a multi-centre double-blind trial. No statistically significant difference between the two groups was found in the number of responders at study-end with the Montgomery and Asberg Depressive Rating Scale, which was the main criterion for efficacy. In addition, amisulpride was well tolerated. These preliminary results suggest that low doses of amisulpride may be effective in the treatment of dysthymic patients.

AB - The efficacy and safety of low doses of amisulpride (50 mg/day) and of fluoxetine (20 mg/day) were compared respectively in 139 and 129 outpatients with dysthymia during three months in a multi-centre double-blind trial. No statistically significant difference between the two groups was found in the number of responders at study-end with the Montgomery and Asberg Depressive Rating Scale, which was the main criterion for efficacy. In addition, amisulpride was well tolerated. These preliminary results suggest that low doses of amisulpride may be effective in the treatment of dysthymic patients.

KW - amisulpride

KW - benzamide

KW - dysthymia

KW - fluoxetine

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=0029936080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029936080&partnerID=8YFLogxK

U2 - 10.1016/0924-9338(96)85189-3

DO - 10.1016/0924-9338(96)85189-3

M3 - Article

VL - 11

JO - Psychiatrie et Psychobiologie

JF - Psychiatrie et Psychobiologie

SN - 0924-9338

IS - SUPPL. 3

ER -